Higher expression of B–cell markers CD19, CD20 in CLL with viral infection suggests a change to atypical CLL, sustained by elevated expression of known poor prognosis markers bcl–2, cyclin D1 and CD38. This evidence concerns the gene CD38 and viral infectious disease.